MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-27-2026
PAVmed DPO Ratio 2011-2026 | PAVM
Annual DPO Ratio PAVmed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 K | 92.1 | 128 | 303 | 1.95 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.95 K | 92.1 | 719 |
Quarterly DPO Ratio PAVmed
| 2025-Q3 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 829 | - | - | 74.4 | 85.6 | - | 85.3 | 65.5 | 134 | - | 195 | 1.57 K | 1.43 K | - | 3.12 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.12 K | 65.5 | 759 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
33.7 | $ 173.14 | -0.8 % | $ 13 B |  USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.17 | -0.41 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 1.89 | - | $ 1.15 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
Inogen
INGN
|
34.6 | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 62.78 | -0.93 % | $ 3.42 B |  Britain |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
146 | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
33.1 | $ 90.42 | -1.07 % | $ 12.2 B | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
Myomo
MYO
|
34.8 | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 77.87 | -1.62 % | $ 45.5 B | USA |